Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 16 May 2020
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 26 (9), 1729-1737
- https://doi.org/10.1016/j.bbmt.2020.05.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Functional hyposplenism after hematopoietic stem cell transplantationBone Marrow Transplantation, 2015
- Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated DonorsJournal of Clinical Oncology, 2013
- Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationBone Marrow Transplantation, 2012
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2010
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillanceBone Marrow Transplantation, 2008
- A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMTBone Marrow Transplantation, 1997
- Loss of protective immunity to polio, diphtheria andHaemophilus influenzaetype b after allogeneic bone marrow transplantationAPMIS, 1996
- Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantationBlood, 1994
- Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantationBlood, 1987